Special Issue "Deciphering the Therapeutic Resistance of Hematologic Malignancies"
Deadline for manuscript submissions: 31 December 2021.
Tumor biology has decades of history in deciphering therapies to fight the hyperproliferative nature of many tumors, especially in hematology. Recent discoveries in stem cell biology have led to the development of the concept of leukemia-initiating cells. Despite many attempts to identify novel drugs with antitumor function, a large proportion of patients relapse or progress onto other therapies. The mechanisms that remain behind therapeutic resistance in leukemias and lymphomas are the subject to this Special Issue of IJMS. We are open to publications that focus on delineating genetic or epigenetic mechanisms of resistance as well as biomarker studies that associate biological parameters with adverse clinical outcome.
Prof. Dr. Tomáš Stopka
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Epigenetic regulation